Cypt3 Inhibitors
Cypt3, also known as Cryptochrome-3, plays a pivotal role in the intricate regulatory network governing circadian rhythms. This protein operates as a transcriptional repressor within the molecular clock machinery, forming complexes with other clock-related proteins to modulate the expression of target genes. Specifically, Cypt3 contributes to the fine-tuning of circadian rhythmicity by orchestrating the timing of various physiological processes in response to external environmental cues, particularly light.
Inhibition of Cypt3 involves disrupting its interactions within the circadian regulatory network. The identified chemical inhibitors impact various signaling pathways indirectly linked to Cypt3 function. For instance, Nobiletin modulates Notch signaling, influencing the expression of genes crucial for Cypt3 regulation. (+/-)-JQ1, a BET inhibitor, disrupts the Bromodomain and Extra-Terminal motif family, impacting the epigenetic landscape and indirectly inhibiting Cypt3 function. LGK-974 inhibits Wnt signaling, affecting downstream events that indirectly impact Cypt3 expression within the cellular regulatory network. Selumetinib, Ibrutinib, Niclosamide, BIX 01294, Tyrphostin B42, GSK1838705A, AZD6244, and DAPT collectively provide a diverse set of inhibitors that interfere with various pathways, influencing factors that ultimately inhibit Cypt3 and its intricate involvement in the regulation of circadian rhythms. Understanding the specific points of intervention and the interconnected pathways involved allows researchers to unravel the complex molecular mechanisms governing the temporal orchestration of physiological processes by Cypt3.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Nobiletin | 478-01-3 | sc-202733 | 10 mg | $189.00 | 2 | |
Nobiletin inhibits Cypt3 indirectly by modulating the Notch signaling pathway, influencing the expression of target genes involved in Cypt3 regulation. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
(+/-)-JQ1, a BET inhibitor, disrupts the Bromodomain and Extra-Terminal motif family, impacting the epigenetic landscape and indirectly inhibiting Cypt3 function. | ||||||
LGK 974 | 1243244-14-5 | sc-489380 sc-489380A | 5 mg 50 mg | $359.00 $1295.00 | 2 | |
LGK-974 inhibits Wnt signaling, influencing downstream events that indirectly impact the expression and function of Cypt3 within the cellular regulatory network. | ||||||
SIS3 hydrochloride | 521984-48-5 | sc-253565 | 5 mg | $334.00 | 2 | |
SIS3, a SMAD3 inhibitor, interferes with the TGF-β signaling pathway, indirectly modulating factors that affect Cypt3 expression and its associated cellular processes. | ||||||
Selumetinib | 606143-52-6 | sc-364613 sc-364613A sc-364613B sc-364613C sc-364613D | 5 mg 10 mg 100 mg 500 mg 1 g | $29.00 $82.00 $420.00 $1897.00 $3021.00 | 5 | |
Selumetinib, a MEK inhibitor, disrupts the MAPK pathway, altering downstream events that indirectly hinder Cypt3 function and its involvement in cellular regulatory networks. | ||||||
Ibrutinib | 936563-96-1 | sc-483194 | 10 mg | $156.00 | 5 | |
Ibrutinib, a BTK inhibitor, impacts B-cell receptor signaling, indirectly influencing Cypt3 expression and function within the complex network of cellular regulatory pathways. | ||||||
Niclosamide | 50-65-7 | sc-250564 sc-250564A sc-250564B sc-250564C sc-250564D sc-250564E | 100 mg 1 g 10 g 100 g 1 kg 5 kg | $38.00 $79.00 $188.00 $520.00 $1248.00 $5930.00 | 8 | |
Niclosamide, a Wnt pathway inhibitor, modulates Wnt signaling, impacting events downstream that indirectly inhibit Cypt3 and its involvement in cellular regulatory networks. | ||||||
BIX01294 hydrochloride | 1392399-03-9 | sc-293525 sc-293525A sc-293525B | 1 mg 5 mg 25 mg | $37.00 $112.00 $408.00 | ||
BIX 01294, a G9a inhibitor, influences histone methylation, indirectly affecting the epigenetic landscape and inhibiting Cypt3 function within the cellular regulatory network. | ||||||
Tyrphostin B42 | 133550-30-8 | sc-3556 | 5 mg | $26.00 | 4 | |
AG-490, a JAK2 inhibitor, interferes with JAK-STAT signaling, modulating factors that indirectly hinder Cypt3 expression and its role in cellular regulatory networks. | ||||||
GSK1838705A | 1116235-97-2 | sc-364502 sc-364502A | 5 mg 50 mg | $240.00 $992.00 | ||
GSK1838705A, a PI3K/mTOR inhibitor, disrupts the PI3K-Akt-mTOR pathway, indirectly influencing factors that inhibit Cypt3 function within the cellular regulatory network. | ||||||